HENRIETTA, N.Y.--(BUSINESS WIRE)--Kamal Sarbadhikari, CEO, SensiVida Medical Technologies, Inc. (OTC BB:SVMT), a company developing minimally invasive diagnostic devices, announced that the Board of Directors and the shareholders of the Company have approved a 10:1 reverse split of its common stock effective on May 18, 2009. The Company’s common stock will be trading on a post-reverse split basis under its new trading symbol, SVMT. This will reduce the number of outstanding shares of the Company’s stock from approximately 117,250,998 to approximately 11,725,099. Corresponding proportional adjustments will be made to any outstanding stock options previously issued by the Company.
